Vivo Opportunity Fund Holdings, L.P. - Sep 30, 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager: Vivo Opportunity Fund Holdings, L.P.
Reporting Manager: Vivo Opportunity Fund Holdings, L.P.
Security: Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol: SLNO
Shares outstanding: 53.6M shares
Disclosed Ownership: 2.25M shares
Ownership: 4.2%
Form type: SCHEDULE 13G/A
Date filed: 11/14/2025, 06:35 PM
Date of event: Sep 30, 2025
Previous filing: Aug 12, 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Vivo Opportunity Fund Holdings, L.P.	4.2%	2.25M	2.25M	/s/ Kevin Dai	Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC	4.2%	2.25M	2.25M	/s/ Kevin Dai	Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P.	0.1%	27K	27K	/s/ Kevin Dai	Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity Cayman, LLC	0.1%	27K	27K	/s/ Kevin Dai	Kevin Dai/Managing Member